Single-agent laromustine, a novel alkylating agent, has significant activity in older patients with previously untreated poor-risk acute myeloid leukemia

Gary J. Schiller, Susan M. O'Brien, Arnaud Pigneux, Daniel J. DeAngelo, Norbert Vey, Jonathan Kell, Scott Solomon, Robert K. Stuart, Verena Karsten, Ann L. Cahill, Maher X. Albitar, Francis J. Giles

Research output: Contribution to journalArticlepeer-review

39 Scopus citations

Fingerprint

Dive into the research topics of 'Single-agent laromustine, a novel alkylating agent, has significant activity in older patients with previously untreated poor-risk acute myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences